Innovation Pharmaceuticals Inc (IPIX)

[Blue Fin]

Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials (a total of 8) for other clinical indications, providing an established safety and efficacy database on over 460 subjects, thereby potentially enabling it to rapidly help address the novel coronavirus crisis.


June 17, 2020
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
Brilacidin
Data from Ongoing Testing at U.S. Regional Biocontainment Laboratory






I agree, you don't appear to know up from down! If you do you should quit dropping the hints that Brilacidin is failing.